Page last updated: 2024-08-25

zoledronic acid and Cancer of the Thyroid

zoledronic acid has been researched along with Cancer of the Thyroid in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's6 (75.00)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Chen, FK; Deng, ZY; Feng, ZP; Hou, F; Jia, L; Liu, C; Liu, PJ; Lv, J; Yang, ZX1
Imamura, Y; Matsuda, S; Sano, K; Umeda, Y; Yoshida, H; Yoshimura, H1
Jung, HD; Jung, YS; Kim, DW; Park, HS1
Manabe, J; Miyata, S; Orita, Y; Sugitani, I; Takao, S; Toda, K1
Gros Herguido, N; Guerrero-Vázquez, R; Martínez Brocca, MA; Moreno Reina, E; Navarro González, E1
Fujimoto, Y; Manabe, J; Orita, Y; Sugitani, I; Toda, K1
Abbruzzese, A; Borghi, MO; Caraglia, M; Castiglioni, S; Colao, A; Crinò, L; Dicitore, A; Faggiano, A; Ferolla, P; Ferone, D; Hofland, L; Ramundo, V; Severino, R; Sperlongano, P; Vitale, G1
Barutca, S; Erdogan, S; Koseoglu, K; Meydan, N; Yurekli, Y1

Other Studies

8 other study(ies) available for zoledronic acid and Cancer of the Thyroid

ArticleYear
Zoledronic acid inhibits thyroid cancer stemness and metastasis by repressing M2-like tumor-associated macrophages induced Wnt/β-catenin pathway.
    Life sciences, 2020, Sep-01, Volume: 256

    Topics: Animals; Antigens, CD; beta Catenin; Cadherins; Carcinogenesis; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation; Humans; Macrophages; Male; Mice; Mice, Nude; Signal Transduction; THP-1 Cells; Thyroid Neoplasms; Tumor Microenvironment; Wnt Signaling Pathway; Zoledronic Acid

2020
Mandibular metastasis as the first clinical indication of occult lung adenocarcinoma with multiple metastases: A case report.
    Medicine, 2018, Volume: 97, Issue:15

    Topics: Adenocarcinoma; Adenocarcinoma of Lung; Aged, 80 and over; Antineoplastic Agents; Biopsy; Bone Density Conservation Agents; Diagnosis, Differential; Diphosphonates; Female; Gefitinib; Humans; Imidazoles; Immunohistochemistry; Lung; Lung Neoplasms; Mandible; Mandibular Neoplasms; Neoplasm Grading; Neoplasm Staging; Quinazolines; Thyroid Neoplasms; Treatment Outcome; Zoledronic Acid

2018
Osteonecrosis of the jaw related to everolimus: a case report.
    The British journal of oral & maxillofacial surgery, 2013, Volume: 51, Issue:8

    Topics: Angiogenesis Inhibitors; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Everolimus; Follow-Up Studies; Humans; Imidazoles; Male; Mandibular Diseases; Middle Aged; Osteonecrosis; Sirolimus; Thyroid Neoplasms; Thyroidectomy; Zoledronic Acid

2013
Prospective Evaluation of Zoledronic Acid in the Treatment of Bone Metastases from Differentiated Thyroid Carcinoma.
    Annals of surgical oncology, 2015, Volume: 22, Issue:12

    Topics: Adult; Aged; Alkaline Phosphatase; Antineoplastic Agents; Biomarkers, Tumor; Bone Neoplasms; Carcinoma; Collagen Type I; Diphosphonates; Disease Progression; Female; Humans; Imidazoles; Male; Middle Aged; Pain; Peptides; Prospective Studies; Response Evaluation Criteria in Solid Tumors; Spinal Cord Compression; Thyroid Neoplasms; Zoledronic Acid

2015
Advanced thyroid carcinoma in pregnancy: case report of two pregnancies.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2015, Volume: 31, Issue:11

    Topics: Adenocarcinoma, Follicular; Adult; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Imidazoles; Iodine Radioisotopes; Lung Neoplasms; Lymph Node Excision; Metastasectomy; Pregnancy; Pregnancy Complications, Neoplastic; Radiotherapy; Spinal Neoplasms; Thyroid Neoplasms; Thyroidectomy; Zoledronic Acid

2015
Zoledronic acid in the treatment of bone metastases from differentiated thyroid carcinoma.
    Thyroid : official journal of the American Thyroid Association, 2011, Volume: 21, Issue:1

    Topics: Adult; Aged; Bone and Bones; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Female; Humans; Imidazoles; Male; Middle Aged; Neoplasm Metastasis; Osteoclasts; Thyroid Neoplasms; Treatment Outcome; Zoledronic Acid

2011
Everolimus is an active agent in medullary thyroid cancer: a clinical and in vitro study.
    Journal of cellular and molecular medicine, 2012, Volume: 16, Issue:7

    Topics: Aged; Apoptosis; beta-Galactosidase; Blotting, Western; Calcitonin; Cell Cycle; Cell Proliferation; Cellular Senescence; Diphosphonates; Everolimus; Humans; Imidazoles; Male; Middle Aged; Sirolimus; Thyroid Neoplasms; Thyroidectomy; Treatment Outcome; Zoledronic Acid

2012
Reversible metastatic visceral calcification detected by 99mTc-methylene diphosphonate bone scanning in breast cancer.
    Journal of bone and mineral metabolism, 2005, Volume: 23, Issue:5

    Topics: Antineoplastic Agents; Bone and Bones; Breast Neoplasms; Calcification, Physiologic; Calcium; Diphosphonates; Female; Heart Neoplasms; Humans; Imidazoles; Lung Neoplasms; Middle Aged; Neoplasm Metastasis; Stomach Neoplasms; Technetium Tc 99m Medronate; Thyroid Neoplasms; Time Factors; Zoledronic Acid

2005